Recent studies indicate that (R)-2-HG can be detected via magnetic resonance imaging (MRI)-based spectroscopy of the brain [48] and in the serum of leukemia and cholangiocarcinoma patients with IDH mutant tumors [49, 50] revealing promising new avenues for cancer detection, staging, and treatment. This evidence concerns the gene IDH2 and cholangiocarcinoma.